FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115273358> ?p ?o ?g. }

• W2115273358 endingPage "1068" @default.
• W2115273358 startingPage "1065" @default.
• W2115273358 abstract "BackgroundA small proportion of strokes are caused by cerebral arteriovenous malformations (AVM). Treatment to prevent intracranial haemorrhage itself carries risks, and untreated AVM may in many cases have a good prognosis. We investigated the risk of subsequent symptomatic bleeding in the clinical course of AVM in patients with and without an initial haemorrhage.Methods281 unselected, consecutive, prospectively enrolled patients with cerebral AVM were grouped according to their initial clinical presentation—142 presented with and 139 without haemorrhage. The frequency of AVM haemorrhages during the subsequent clinical course (before the start of endovascular, surgical, or radiation treatment) in the two groups was compared by means of Kaplan-Meier life-tables, log-rank test, and multivariate proportional-hazards regression models. Haemorrhage was defined as a clinically symptomatic event with signs of acute bleeding on computed tomography or magnetic resonance brain imaging.FindingsDuring mean follow-up of 8·5 months for the haemorrhage group and 11·9 months for the non-haemorrhage group, haemorrhages occurred in 18 (13%) of the former patients and in three (2%) of the latter (p=0·0002). The annual risk of haemorrhage was 17·8% and 2·2%, respectively. In the multivariate regression model, the adjusted hazard ratio for haemorrhage at initial presentation was 13·9 (95% Cl 2·6–73·8; p=0·002). Deep venous drainage (hazard ratio 4·1 [1·2–14·9], p=0·029) and male sex (9·2 [2·1–41·3], p=0·004) were also significantly associated with subsequent haemorrhage, but no significant association was found for age or AVM size. The annual rate of spontaneous haemorrhage was 32·6% for men and 10·4% for women in the haemorrhage group compared with 3·3% for men and 1·3% for women in the non-haemorrhage group. Among patients with haemorrhage at initial presentation, the risk of haemorrhage fell from 32·9% in year 1 to 11·3% in subsequent years (34·2% to 31·0% in men; 31·1% to 5·5% in women).InterpretationIn AVM, patients initially presenting with haemorrhage have a higher risk of subsequent bleeding than those presenting with other symptoms. The risk is higher in men than in women. A small proportion of strokes are caused by cerebral arteriovenous malformations (AVM). Treatment to prevent intracranial haemorrhage itself carries risks, and untreated AVM may in many cases have a good prognosis. We investigated the risk of subsequent symptomatic bleeding in the clinical course of AVM in patients with and without an initial haemorrhage. 281 unselected, consecutive, prospectively enrolled patients with cerebral AVM were grouped according to their initial clinical presentation—142 presented with and 139 without haemorrhage. The frequency of AVM haemorrhages during the subsequent clinical course (before the start of endovascular, surgical, or radiation treatment) in the two groups was compared by means of Kaplan-Meier life-tables, log-rank test, and multivariate proportional-hazards regression models. Haemorrhage was defined as a clinically symptomatic event with signs of acute bleeding on computed tomography or magnetic resonance brain imaging. During mean follow-up of 8·5 months for the haemorrhage group and 11·9 months for the non-haemorrhage group, haemorrhages occurred in 18 (13%) of the former patients and in three (2%) of the latter (p=0·0002). The annual risk of haemorrhage was 17·8% and 2·2%, respectively. In the multivariate regression model, the adjusted hazard ratio for haemorrhage at initial presentation was 13·9 (95% Cl 2·6–73·8; p=0·002). Deep venous drainage (hazard ratio 4·1 [1·2–14·9], p=0·029) and male sex (9·2 [2·1–41·3], p=0·004) were also significantly associated with subsequent haemorrhage, but no significant association was found for age or AVM size. The annual rate of spontaneous haemorrhage was 32·6% for men and 10·4% for women in the haemorrhage group compared with 3·3% for men and 1·3% for women in the non-haemorrhage group. Among patients with haemorrhage at initial presentation, the risk of haemorrhage fell from 32·9% in year 1 to 11·3% in subsequent years (34·2% to 31·0% in men; 31·1% to 5·5% in women). In AVM, patients initially presenting with haemorrhage have a higher risk of subsequent bleeding than those presenting with other symptoms. The risk is higher in men than in women. Cerebral arteriovenous malformations (AVM) are the underlying cause of a small proportion of all strokes, but typically affect otherwise healthy young adults. The main goal of AVM treatment by modern endovascular techniques, microsurgery, and radiosurgery is the prevention of intracranial haemorrhage and its attendant brain injury. However, treatment itself carries a small but substantial risk, and the natural course of many AVM cases may be benign.1Marconi F Parenti G Puglioli M Spontaneous regression of intracranial arteriovenous malformations.Surg Neurol. 1993; 39: 385-391Summary Full Text PDF PubMed Scopus (21) Google Scholar, 2McCormick WF Rosenfield DB Massive brain haemorrhage: a review of 144 cases and an examination of their causes.Stroke. 1973; 4: 946-954Crossref PubMed Scopus (204) Google Scholar, 3McCormick WF Pathology of vascular malformations of the brain.in: Wilson CB Stein BM Intracranial arteriovenous malformations. Williams & Wilkins, Baltimore1984: 44-63Google Scholar Therefore, clinical, morphological, and haemodynamic risk predictors for untreated AVM are needed to enable better clinical decision-making. Retrospective analyses of selected series have suggested that the mode of initial clinical presentation of AVM may provide a marker for the subsequent risk of bleeding. Crawford and colleagues’review4Crawford PM West CR Chadwick DW Shaw MDM Arteriovenous malformations of the brain: natural history in unoperated patients.J Neurol Neurosurg Psychiatry. 1986; 49: 1-10Crossref PubMed Scopus (589) Google Scholar suggested that patients who initially presented with haemorrhage had a greater rate of haemorrhage during the subsequent course than did those presenting with other symptoms. Subsequent reports on smaller5Marks MP, Bracci P, Steinberg GK. Natural history of cerebral AVMs correlated with angiographic risk factors of hemorrhage. American Society of Neuroradiology 31st Annual Meeting, May 16–20, 1993; Vancouver, BC, Canada, 1993: 75.Google Scholar or highly selected6Pollock BE Flickinger JC Lunsford LD Bissonette DJ Kondziolka D Factors that predict the bleeding risk of cerebral arteriovenous malformations.Stroke. 1996; 27: 1-6Crossref PubMed Scopus (250) Google Scholar samples supported these observations. No study so far has investigated identifiable independent predictors for haemorrhage in the clinical course after AVM diagnosis—such as lesion size or drainage pattern—in unselected, untreated patients. We undertook such a study. The Columbia-Presbyterian Medical Center AVM databank is a prospective database on all patients with cerebral AVM examined at the centre. The database includes demographic, clinical, laboratory, and treatment data since 1987. As a tertiary centre, specialising in cerebrovascular diseases and neurosurgical, endovascular, and radiosurgical treatment, our institution draws patients from the New York metropolitan area as well as from distant referral sites. The study was based on prospective enrolment between January, 1987, and May, 1996, of consecutive patients with retrospective assessment of initial AVM presentation. Table 1 shows baseline characteristics and initial AVM symptoms of the study sample. 142 patients initially presented with haemorrhage, defined as a clinically symptomatic event (sudden-onset headache, seizure, focal deficit, or a combination of these features) with signs of fresh bleeding on computed tomography or magnetic resonance brain imaging (haemorrhage group). The same criteria were used for the diagnosis of haemorrhage during the follow-up period. The remaining 139 patients initially presented with symptoms or signs unrelated to haemorrhage (table 1) and served as the comparison group (non-haemorrhage group). Insufficient information was available for us to judge whether haemorrhage had occurred in an additional 15 cases excluded from the analysis.Table 1Baseline characteristics and initial presentation in 281 prospectively enrolled consecutive patients with cerebral AVMHaemorrhage group (n=142)Non-haemorrhage group (n=139)Total (n=281)DemographyMean (SD) age in years35·9 (13·9)33·6 (11·8)34·8(12·9)Male/female71 (50%)/71 (50%)62 (45%)/77 (55%)133 (47%)/148 (53%)AVM characteristicsSmall size32 (23%)10 (7%)42 (15%)Deep drainage42 (30%)9 (6%)51 (18%)Infratentorial location23 (16%)7 (5%)30 (11%)Initial AVM presentationHaemorrhage142 (100%)˙˙142 (51%)Seizure†No signs of haemorrhage on imaging.˙˙75 (54%)75 (27%)Chronic headachet˙˙30 (22%)30 (11%)Focal deficit†No signs of haemorrhage on imaging.˙˙14 (10%)14 (5%)No symptoms†No signs of haemorrhage on imaging.˙˙7 (5%)7 (3%)Unclassified†No signs of haemorrhage on imaging.˙˙13 (9%)13 (5%)Data are number (%) of patients unless otherwise specified.*By Stein and Kader9Stein BM Kader A Intracranial arteriovenous malformations.Clin Neurosurg. 1992; 39: 76-113PubMed Google Scholar criteria: small AVM=maximum diameter 2·5 cm.† No signs of haemorrhage on imaging. Open table in a new tab Data are number (%) of patients unless otherwise specified. *By Stein and Kader9Stein BM Kader A Intracranial arteriovenous malformations.Clin Neurosurg. 1992; 39: 76-113PubMed Google Scholar criteria: small AVM=maximum diameter 2·5 cm. To ensure that the observation period did not include time under treatment, patients who underwent endovascular, surgical, or radiation procedures were censored (ie, withdrawn from life-table analysis) at the start of any such therapy. Patients with one or more haemorrhages after initial presentation were censored at the first haemorrhage event. Kaplan-Meier life-tables were constructed for the frequency of AVM haemorrhage in the two groups during follow-up. The significance of group differences was assessed with the log-rank test. In addition, a multivariate proportional-hazards regression model, which included all modes of initial AVM presentation, was constructed. Previous studies have suggested that small AVM size and deep-venous AVM drainage are predictors of an increased risk of AVM haemorrhage.5Marks MP, Bracci P, Steinberg GK. Natural history of cerebral AVMs correlated with angiographic risk factors of hemorrhage. American Society of Neuroradiology 31st Annual Meeting, May 16–20, 1993; Vancouver, BC, Canada, 1993: 75.Google Scholar, 7Kader A Young WL Pile-Spellman J et al.The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations.Neurosurgery. 1994; 34: 801-808Crossref PubMed Scopus (246) Google Scholar, 8Marks MP Lane B Steinberg GK Chang PJ Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants.Radiology. 1990; 176: 807-813Crossref PubMed Scopus (223) Google Scholar A further regression model (including AVM size and drainage, as well as the patient's age and sex, and initial haemorrhage) tested the effect of these factors. AVM size definition followed the generally accepted Stein and Kader classification9Stein BM Kader A Intracranial arteriovenous malformations.Clin Neurosurg. 1992; 39: 76-113PubMed Google Scholar (table 1). Patients whose angiograms showed venous AVM drainage exclusively through the periventricular, Galenic, or cerebellar pathways were classified as having deep-venous drainage. The study was reviewed and approved by the ethics committee of the Columbia-Presbyterian Medical Center. Haemorrhage during follow-up before start of treatment occurred in 18 (13%) patients in the haemorrhage group and in three (2%) of those without previous haemorrhage. The mean follow-up time was 8·5 months (range 0·1–96·4) in the haemorrhage group and 11·9 months (0·4–90·9) in the non-haemorrhage group. The annual rate of bleeding after initial AVM presentation was 17·8% in the haemorrhage group and 2·2% in the non-haemorrhage group. The annual rate of bleeding was higher for the first year (32·9%) than in subsequent years (11·3%) in the haemorrhage group. By contrast, in the non-haemorrhage group, the rate was 0% for the first year and 2·9% for subsequent years. Haemorrhage during follow-up was significantly associated with clinical presentation of haemorrhage as the initial symptom (hazard ratio 7·5 [95% CI 2·2–25·7]; p=0·0002, figure 1). Actuarial estimates of the cumulative 5-year risk of haemorrhage after initial presentation were 58% (SE 12) in the haemorrhage group and 10% (7) in the non-haemorrhage group. The regression model that included all modes of initial AVM presentation also showed a significant association of haemorrhage during follow-up with initial haemorrhage (6·7 [1·6–28·8]) but no significant effect was found for initial presentation with seizure (1·2 [0·3–5·4]), focal deficit (1·1 [0·4–3·1]), or headache (1·7 [0·6–4·5]). The effect of initial presentation with haemorrhage remained significant in the regression model that included age, sex, small AVM size, and deep drainage (table 2). In this model, significant associations with haemorrhage during follow-up were also found for male sex and exclusively deep-venous drainage. Small AVM size and age had no effect.Table 2Results of regression analysisHazard ratio (95% Cl)pHaemorrhage as initial AVM presentation13·9 (2·6–73·8)0·002Age1·2 (0·8–1·7)0·421Male sex9·2 (2·1–41·3)0·004Small AVM size1·3 (0·3–5·8)0·725Deep drainage4·1 (1·2–14·9)0·029Owing to missing data (undefined venous drainage pattern or undefined AVM size), 49 of 281 patients omitted from analysis. Open table in a new tab Owing to missing data (undefined venous drainage pattern or undefined AVM size), 49 of 281 patients omitted from analysis. Although initial presentation with haemorrhage was a significant risk factor in both sexes, the difference in risk of spontaneous haemorrhage between patients who did and did not present initially with haemorrhage was greater for men than for women (figure 2). Calculated annual event rates were 32·6% for men and 10·4% for women initially presenting with haemorrhage and 3·3% for men and 1·3% for women not initially presenting with haemorrhage. Among women in the haemorrhage group, the risk of spontaneous subsequent haemorrhage fell from 31·1% in year 1 to 5·5% in subsequent years; no similar trend was found among men (34·2% in year 1 and 31·0% in subsequent years). The comparison of the rates of haemorrhage in the two groups after year 1 (11·3 vs 2·9%) lacked statistical power (53 patients), but gave a hazard ratio of 3·14 (0·81–12·23; p=0·08). For 11 (52%) of the 21 patients with an AVM haemorrhage during follow-up, no associated neurological deficit was found. Among the ten with deficits, these were non-disabling or mildly disabling (Rankin scale scores <3, independence on Barthel score) in eight. The other two had disabling deficits (Rankin scale scores 3 and 5). None of the patients died. Follow-up haemorrhages were exclusively intraventicular in eight (38%) patients, intraparenchymatous in six (28%), subarachnoidal in two (10%), combined intraparenchymatous and intraventricular in four (19%), and undefined in one. Ten of the 11 patients without any neurological deficit had an exclusively intraventricular or subarachnoidal haemorrhage. Similarly, a focal neurological deficit related to the initial presentation haemorrhage was found in only 50 (35·2%) of the 142 haemorrhage-group patients; a disabling deficit was seen in only seven (4·9%) cases. Our study shows a significantly higher risk of subsequent haemorrhage for AVM patients who initially present with haemorrhage than for patients with non-haemorrhagic presentation. This finding supports the idea of prognostically distinct AVM subgroups. Pooled data for 1860 reported AVM cases suggested that roughly 60% present with haemorrhage.10Mast H Mohr JP Osipov A et al.‘Steal’is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations.Stroke. 1995; 26: 1215-1220Crossref PubMed Scopus (156) Google Scholar In the few estimates available, the rate of haemorrhage in the course of untreated AVM was between 2% and 4% per year.4Crawford PM West CR Chadwick DW Shaw MDM Arteriovenous malformations of the brain: natural history in unoperated patients.J Neurol Neurosurg Psychiatry. 1986; 49: 1-10Crossref PubMed Scopus (589) Google Scholar, 11Ondra SL Troupp H George ED Schwab K The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.J Neurosurg. 1990; 73: 387-391Crossref PubMed Scopus (875) Google Scholar A higher rate has been reported for patients initially presenting with haemorrhage than for patients with other diagnostic symptoms.4Crawford PM West CR Chadwick DW Shaw MDM Arteriovenous malformations of the brain: natural history in unoperated patients.J Neurol Neurosurg Psychiatry. 1986; 49: 1-10Crossref PubMed Scopus (589) Google Scholar, 5Marks MP, Bracci P, Steinberg GK. Natural history of cerebral AVMs correlated with angiographic risk factors of hemorrhage. American Society of Neuroradiology 31st Annual Meeting, May 16–20, 1993; Vancouver, BC, Canada, 1993: 75.Google Scholar, 6Pollock BE Flickinger JC Lunsford LD Bissonette DJ Kondziolka D Factors that predict the bleeding risk of cerebral arteriovenous malformations.Stroke. 1996; 27: 1-6Crossref PubMed Scopus (250) Google Scholar Our findings extend these observations in a prospective study, which shows a larger annual risk of haemorrhage overall (10%), and an especially high rate in the group of patients initially presenting with haemorrhage (18%). We cannot exclude the possibility that referral patterns to our centre may have affected the findings. However, our data set includes all (seven) of the cases of AVM discovered in the population of about 250 000 who constitute the Northern Manhattan Stroke Study cohort.12Sacco RL Kargman DE Gu Q Zamanillo MC Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study.Stroke. 1995; 26: 14-20Crossref PubMed Scopus (818) Google Scholar That population is not of the very large size needed to generate as many cases of AVM as we report here. Until such sufficiently large studies can be undertaken, our data and the smaller sets available may have to suffice for risk estimations in AVM patients. Other samples of patients with AVM had baseline characteristics similar to those of our patients.4Crawford PM West CR Chadwick DW Shaw MDM Arteriovenous malformations of the brain: natural history in unoperated patients.J Neurol Neurosurg Psychiatry. 1986; 49: 1-10Crossref PubMed Scopus (589) Google Scholar, 5Marks MP, Bracci P, Steinberg GK. Natural history of cerebral AVMs correlated with angiographic risk factors of hemorrhage. American Society of Neuroradiology 31st Annual Meeting, May 16–20, 1993; Vancouver, BC, Canada, 1993: 75.Google Scholar, 6Pollock BE Flickinger JC Lunsford LD Bissonette DJ Kondziolka D Factors that predict the bleeding risk of cerebral arteriovenous malformations.Stroke. 1996; 27: 1-6Crossref PubMed Scopus (250) Google Scholar, 8Marks MP Lane B Steinberg GK Chang PJ Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants.Radiology. 1990; 176: 807-813Crossref PubMed Scopus (223) Google Scholar, 10Mast H Mohr JP Osipov A et al.‘Steal’is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations.Stroke. 1995; 26: 1215-1220Crossref PubMed Scopus (156) Google Scholar, 11Ondra SL Troupp H George ED Schwab K The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.J Neurosurg. 1990; 73: 387-391Crossref PubMed Scopus (875) Google Scholar Thus, we believe that our sample is representative of the general AVM population. Some investigators have found no association of initial haemorrhage with further bleeding events in the subsequent clinical course. In a selected sample of 160 AVM cases followed up retrospectively over 24 years, Ondra and colleagues11Ondra SL Troupp H George ED Schwab K The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.J Neurosurg. 1990; 73: 387-391Crossref PubMed Scopus (875) Google Scholar found no such association. Modern brain imaging and microsurgical techniques were not available for some of their cases, and a selection bias may have been introduced by choice of patients deemed surgically untreatable, thereby shifting cases with large-sized and deeply located AVMs in eloquent brain areas into their sample. Most previous studies have reported haemorrhage as a single clinical entity, without giving details of severity; this approach implies that the event alone carries a uniform serious prognosis. Our data suggest the haemorrhagic event itself may be less serious than has been assumed. This finding would be of special interest had it been from a truly population-based study, but we cannot exclude the possibility of selection bias from the referral patterns in our cohort. Furthermore, our study does not provide data on the mortality of initial haemorrhages. Because of the available treatment options and current concerns about serious outcomes from haemorrhage, prospective natural-course studies in unselected samples of patients with AVM will continue to be difficult. Neither previously reported series nor our study can be taken as long-term prospective natural history investigations. Current clinical practice assumes a steady uniform long-term risk of AVM bleeding, but there are no observations to justify this notion. Our finding of a declining risk of haemorrhage over time in patients with haemorrhage at initial presentation may support the hypothesis of an improvement of the long-term risk of AVM haemorrhage.13Fults D Kelly DL Natural history of arteriovenous malformations of the brain: a clinical study.Neurosurgery. 1984; 15: 658-662Crossref PubMed Scopus (329) Google Scholar, 14Itoyama Y Uemura S Ushio Y et al.Natural course of unoperated arteriovenous malformations: study of 50 cases.J Neurosurg. 1989; 71: 805-809Crossref PubMed Scopus (191) Google Scholar Therefore, the cumulative 5-year risk estimates yielded by our investigation have to be applied cautiously and may be viewed as a useful starting point for future studies. On the other hand, a 33% first-year rate of haemorrhage alone may well be viewed as a substantial risk, justifying invasive treatment. Previous work7Kader A Young WL Pile-Spellman J et al.The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations.Neurosurgery. 1994; 34: 801-808Crossref PubMed Scopus (246) Google Scholar, 8Marks MP Lane B Steinberg GK Chang PJ Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants.Radiology. 1990; 176: 807-813Crossref PubMed Scopus (223) Google Scholar, 15Spetzler RF Hargraves RW McCormick PW Zabramski JM Flom RA Zimmerman RS Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations.J Neurosurg. 1992; 76: 918-923Crossref PubMed Scopus (331) Google Scholar suggested an association of deep AVM drainage, small AVM size, and high feeding-artery pressure with initial presentation with haemorrhage, and implicated them as predictors of subsequent haemorrhage. Our data also show that deep-venous drainage is a strong and independent determinant of subsequent haemorrhage in the clinical course after AVM diagnosis. No such effect was found for small-sized AVMs but there were few small AVMs in our sample, so an association may not be detectable. The higher risk of haemorrhage for men than for women has not been reported previously and remains unexplained. The emerging set of clinical and morphological criteria defining AVM patients at higher risk of spontaneous bleeding should prove helpful in the decision-making process in individual patients and in the design of future outcome studies testing treatment effects. Contributors Henning Mast initiated and coordinated the formulation of the primary study hypothesis, discussed core ideas, designed the protocol particularly the documentation of clinical neurological data, and participated in data collection, analysis, and writing of the paper. William Young, the principal investigator of the Columbia-Presbyterian AVM Study Project, initiated the research, discussed core ideas, and participated in the protocol design, analysis and interpretation of the data, and writing of the paper. Hans-Christian Koennecke paticipated in the study design, data collection, and analysis, and edited the paper. Robert Sciacca initiated the research, participated in data documentation, analysed and interpreted the data, and contributed to writing of the paper. Andrei Osipov participated in the design and execution of the study particularly data collection, data documentation, and quality control, participated in the statistical analysis, and edited the paper. John Pile-Spellman initiated the reaserch, participated in data collection particularly on morphological aspects of AVM, discussed core ideas, and edited the paper. Lotfi Hacein-Bey and Hoang Duong participated in the design and execution (particularly neuroradiological aspects of AVM and morphological AVM classification), and edited the paper. Bennett Stein initiated the AVM research project, discussed core issues of the study and its design, collected data, and contributed to the paper. J P Mohr initiated the AVM research project, participated in the design of the study protocol, collected data, discussed core ideas and interpretation of the findings, and contributed to the paper. Acknowledgments The study was supported by grants NS27713 and NS34949 from the National Institutes of Health." @default.
• W2115273358 created "2016-06-24" @default.
• W2115273358 creator A5002958762 @default.
• W2115273358 creator A5007302818 @default.
• W2115273358 creator A5017446485 @default.
• W2115273358 creator A5026699335 @default.
• W2115273358 creator A5028284967 @default.
• W2115273358 creator A5029518995 @default.
• W2115273358 creator A5043755452 @default.
• W2115273358 creator A5049378459 @default.
• W2115273358 creator A5069226088 @default.
• W2115273358 creator A5091074938 @default.
• W2115273358 date "1997-10-01" @default.
• W2115273358 modified "2023-10-18" @default.
• W2115273358 title "Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation" @default.
• W2115273358 cites W1965061510 @default.
• W2115273358 cites W1980205676 @default.
• W2115273358 cites W2009279657 @default.
• W2115273358 cites W2035742925 @default.
• W2115273358 cites W2048020454 @default.
• W2115273358 cites W2050529289 @default.
• W2115273358 cites W2068139009 @default.
• W2115273358 cites W2073201169 @default.
• W2115273358 cites W2102766489 @default.
• W2115273358 cites W2124552328 @default.
• W2115273358 cites W2148538425 @default.
• W2115273358 doi "https://doi.org/10.1016/s0140-6736(97)05390-7" @default.
• W2115273358 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10213548" @default.
• W2115273358 hasPublicationYear "1997" @default.
• W2115273358 type Work @default.
• W2115273358 sameAs 2115273358 @default.
• W2115273358 citedByCount "452" @default.
• W2115273358 countsByYear W21152733582012 @default.
• W2115273358 countsByYear W21152733582013 @default.
• W2115273358 countsByYear W21152733582014 @default.
• W2115273358 countsByYear W21152733582015 @default.
• W2115273358 countsByYear W21152733582016 @default.
• W2115273358 countsByYear W21152733582017 @default.
• W2115273358 countsByYear W21152733582018 @default.
• W2115273358 countsByYear W21152733582019 @default.
• W2115273358 countsByYear W21152733582020 @default.
• W2115273358 countsByYear W21152733582021 @default.
• W2115273358 countsByYear W21152733582022 @default.
• W2115273358 countsByYear W21152733582023 @default.
• W2115273358 crossrefType "journal-article" @default.
• W2115273358 hasAuthorship W2115273358A5002958762 @default.
• W2115273358 hasAuthorship W2115273358A5007302818 @default.
• W2115273358 hasAuthorship W2115273358A5017446485 @default.
• W2115273358 hasAuthorship W2115273358A5026699335 @default.
• W2115273358 hasAuthorship W2115273358A5028284967 @default.
• W2115273358 hasAuthorship W2115273358A5029518995 @default.
• W2115273358 hasAuthorship W2115273358A5043755452 @default.
• W2115273358 hasAuthorship W2115273358A5049378459 @default.
• W2115273358 hasAuthorship W2115273358A5069226088 @default.
• W2115273358 hasAuthorship W2115273358A5091074938 @default.
• W2115273358 hasBestOaLocation W21152733581 @default.
• W2115273358 hasConcept C126838900 @default.
• W2115273358 hasConcept C2778749279 @default.
• W2115273358 hasConcept C2779603958 @default.
• W2115273358 hasConcept C2780643987 @default.
• W2115273358 hasConcept C2910939485 @default.
• W2115273358 hasConcept C71924100 @default.
• W2115273358 hasConceptScore W2115273358C126838900 @default.
• W2115273358 hasConceptScore W2115273358C2778749279 @default.
• W2115273358 hasConceptScore W2115273358C2779603958 @default.
• W2115273358 hasConceptScore W2115273358C2780643987 @default.
• W2115273358 hasConceptScore W2115273358C2910939485 @default.
• W2115273358 hasConceptScore W2115273358C71924100 @default.
• W2115273358 hasIssue "9084" @default.
• W2115273358 hasLocation W21152733581 @default.
• W2115273358 hasLocation W21152733582 @default.
• W2115273358 hasOpenAccess W2115273358 @default.
• W2115273358 hasPrimaryLocation W21152733581 @default.
• W2115273358 hasRelatedWork W1967173859 @default.
• W2115273358 hasRelatedWork W1980037972 @default.
• W2115273358 hasRelatedWork W1980639143 @default.
• W2115273358 hasRelatedWork W1990100747 @default.
• W2115273358 hasRelatedWork W2028388158 @default.
• W2115273358 hasRelatedWork W2074553565 @default.
• W2115273358 hasRelatedWork W2161190409 @default.
• W2115273358 hasRelatedWork W2335613826 @default.
• W2115273358 hasRelatedWork W2355154077 @default.
• W2115273358 hasRelatedWork W2369636485 @default.
• W2115273358 hasVolume "350" @default.
• W2115273358 isParatext "false" @default.
• W2115273358 isRetracted "false" @default.
• W2115273358 magId "2115273358" @default.
• W2115273358 workType "article" @default.